Home/Darwin Biosciences/Amy Emerman, Ph.D.

AE

Amy Emerman, Ph.D.

Director, Product Development

Darwin Biosciences

Therapeutic Areas

Sepsis Infectious Diseases

Darwin Biosciences Pipeline

Drug	Indication	Phase
Sepsis Detection Assay	Early detection of sepsis	Pre-clinical
Platform Partnership Development	Various (Human & Animal Health)	Discovery/Partnership

Leadership Team at Darwin Biosciences

Nick Meyerson, Ph.D.

CEO and Co-Founder

Sara Sawyer, Ph.D.

Director and Co-Founder

Claire Alexander, B.S.N., M.B.A.

VP Clinical Affairs and Operations

View full Darwin Biosciences profile